Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 26, 2025

Best Legal Steroids For Muscle Growth: Top Anabolic Steroids Alternatives For (Bulking & Bodybuilding) That Really Work – By Crazy Bulk
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- Legal steroids are not technically steroids. Legal steroids are a unique combination of natural ingredients (multi-ingredient supplement) that mimic the steroids, they work like steroids minus the side …

Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH
SOUTH SAN FRANCISCO, Calif., April 26, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the results of long-term data demonstrating that the investigational Zenflow Spring® System offers significant and durable benefits three years after placement. …

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co-founders, Mads …

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of …

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unresponsive patients TARA-002 demonstrates 76% complete response rate at any time and 43% 12-month landmark complete response rate in BCG …

RAD-140 SARMs – Rad 140 Testolone Benefits, Dosage, Safety, and Where to Buy Sarms Online (by Crazy Bulk USA)
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- The fitness and bodybuilding industry is constantly evolving, with athletes and enthusiasts always on the lookout for safe and effective performance enhancers. Selective Androgen Receptor Modulators (SARMs), …

Best Male Enhancement Pills For Men: Top OTC Sex Pills To Perform Better And Erectile Dysfunction, Over The Counter ED Pills (Performer 8)
GLASGOW, United Kingdom, April 26, 2025 (GLOBE NEWSWIRE) -- Performer 8: A Natural Male Health Supplement How Does Performer 8 Work? As men age, especially after 40, they may face health issues like low energy, reduced confidence, and other challenges. …

Levicept Presents Positive Phase II Data for Novel Neurotrophin-3 Inhibitor, LEVI-04, at 2025 World Congress on Osteoarthritis
Plenary presentation of data showing primary efficacy endpoint met – significant analgesia across all doses Significant improvement in all signs and symptoms of osteoarthritis for all doses Poster presentation of imaging data showing no increase in …

Mitolyn Reviews 2025 (WARNING) Purple Peel Exploit Scientific Evidence, Complaints & What the Users Says About Mitochondrial Support!
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- More individuals wish to lose weight, feel more energetic, and become healthier. While most weight loss supplements offer immediate results, they can damage your long-term health. That's where Mitolyn fits …

VitaSeal Reviews (EXPERT OPINION) Does VitaSeal Really Work For Diabetes or Is It Just Hype? (Pros & Cons)
MINNEAPOLIS, April 26, 2025 (GLOBE NEWSWIRE) -- VitaSeal is a natural blood sugar control formula that has been receiving much hype lately. The manufacturer claims this supplement is a combination of natural ingredients that are scientifically proven to …

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on April 23, 2025, the Board of …